[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 353 Engrossed in House (EH)]


                In the House of Representatives, U. S.,

                                                         June 26, 2008.
Whereas the annual commemoration of Men's Health Week during the week preceding 
        Father's Day gives new reason to consider the critical need to improve 
        detection and treatment of prostate cancer;
Whereas prostate cancer now strikes at least one in six American men, with 
        African-American men having a 60 percent higher incidence rate than 
        Caucasian men and a mortality rate twice as high;
Whereas each year more than 230,000 American men are newly diagnosed with 
        prostate cancer, more than 1,500,000 men have biopsies, and around 
        30,000 men fall prey to this potential killer;
Whereas it is important for men to take advantage of prostate cancer screening 
        exams in order to detect the disease at the earliest opportunity, when 
        it is still curable;
Whereas a recent study funded by the National Cancer Institute demonstrated that 
        the most common available methods of detecting prostate cancer, the PSA 
        blood test and physical exams, are not foolproof--imaging would be 
        another beneficial factor in the diagnosis and treatment of prostate 
        cancer;
Whereas the use of advanced imaging technologies to detect and treat prostate 
        cancer could be beneficial for eliminating unnecessary and costly 
        medical procedures that increase psychological and emotional trauma for 
        American men and their families;
Whereas the lack of accurate imaging tools means that biopsies can miss cancer 
        even when multiple samples are taken, and current treatments--either 
        radical surgery or radiation--can leave 50 to 80 percent of men 
        incontinent or impotent or both; and
Whereas advanced imaging technologies could be combined with treatment tools to 
        perform image-guided, minimally invasive and precisely targeted 
        interventions, which will be performed in outpatient clinics with 
        minimal discomfort, complications and costs and which will end the fear, 
        pain, suffering and costs that prostate cancer causes men and their 
        families: Now, therefore, be it
    Resolved, That it is the sense of the House of Representatives that there 
should be increased support for research and development of advanced imaging 
technologies for prostate cancer detection and treatment.
            Attest:

                                                                          Clerk.